Gujarat Alkalies & Chemicals Ltd (GUJALKALI) — shareholding pattern, promoter holding, financials and share price

About Gujarat Alkalies & Chemicals Ltd (GUJALKALI)

Gujarat Alkalies & Chemicals Ltd operates in the Commodity Chemicals industry, within the Chemicals sector. It trades on the NSE as GUJALKALI and on the BSE under scrip code 530001. Its ISIN is INE186A01019.

Incorporated in 1973, Gujarat Alkalies and Chemicals Ltd is promoted by the Government of Gujarat, with promoter-group shareholding of 47.28% as of FY26. The company operates manufacturing complexes at Vadodara and Dahej, Gujarat, and has 50+ years of operating history in chlor-alkali and allied chemicals. [1]

Gujarat Alkalies and Chemicals Limited (GACL) is a leading producer of various chemical products, including Caustic Soda, with significant market operations in India and abroad.

GACL has shown a strong commitment towards expanding its green energy initiatives, evident by its extensive wind and solar power projects, with total renewable energy capacity reaching over 200 MW.

Listed peers in Commodity Chemicals: Tanfac Industries Ltd, GHCL Ltd, Grauer & Weil (India) Ltd, Chemplast Sanmar Ltd, Thirumalai Chemicals Ltd, J.G.Chemicals Ltd.

Valuation & Returns

10 Jul 2026

At ₹590 a share on 10 Jul 2026, Gujarat Alkalies & Chemicals Ltd (GUJALKALI) was valued at a price-to-earnings ratio of -1,797x against an industry P/E of 45.11x and a price-to-book of 0.76x on a book value of ₹772.03 per share as of Mar 2025. Solomo computes return on equity of -0.04% and return on capital employed of 1.35% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.

P/E
-1,797x
Industry P/E
45.11x
P/B
0.76x
EPS (TTM)
₹-0.33
Book value / share
₹772.03
ROE
-0.04%
ROCE
1.35%
ROA
-0.03%
Debt / equity
0.1x
Dividend yield
2.68%
EBITDA margin
11.44%
52-week range
₹410 – ₹815

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, Gujarat Alkalies & Chemicals Ltd (GUJALKALI) reported revenue of ₹4,358 crore, net profit of ₹-2 crore and earnings per share of ₹-0.33. That compares with revenue of ₹4,073 crore and net profit of ₹-65 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹1,125 crore and net profit ₹15 crore (consolidated).

Consolidated annual results for Gujarat Alkalies & Chemicals Ltd (GUJALKALI), Mar 2022 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue (₹ cr)3,7594,5163,8074,0734,358
Net profit (₹ cr)560410-237-65-2
EPS (₹)76.2255.78-32.25-8.87-0.33
Compound annual growth for Gujarat Alkalies & Chemicals Ltd (GUJALKALI). Stock price CAGR is price return and excludes dividends.
Measure10Y5Y3Y1Y
Sales growth6.98%8.37%2.71%7.00%
Profit growth-25.36%-45.63%-69.58%72.50%
Stock price CAGR10%5%-5%-1%

Ownership Summary

Jun 2026

As of Jun 2026, promoters hold 47.28% of Gujarat Alkalies & Chemicals Ltd (GUJALKALI) (unchanged from the previous quarter), foreign institutional investors (FII) hold 3.26% and domestic institutional investors (DII) hold 3.02%. Market capitalisation was ₹4,333 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.

Largest disclosed public shareholders in Jun 2026: Lok Prakashan Ltd 22.15%, Gujarat State Fertilizers & Chemicals Limited 2.25%, Meridian Chem Bond Private Limited 2.24%, Shreyans Shantilal Shah 1.76%, The New India Assurance Company Limited 1.58%, Gujarat Industries Power Company Ltd. 1.5%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Jun 202647.28%-3.26%3.02%52.72%
Mar 202647.28%-0.94%3.73%52.72%
Dec 202546.28%-0.96%4.75%53.72%
Sep 202546.28%-1.02%4.53%53.72%
Jun 202546.28%-1.02%4.35%53.72%
Mar 202546.28%-1.71%4.17%53.72%
Dec 202446.28%-1.79%4.14%53.72%
Sep 202446.28%-1.94%3.77%53.72%
Every quarter since Mar 2001 Filing data, not investment advice.